I. Ricca

M. Boccadoro, M. Ladetto, D. Drandi, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

A. Pileri, M. Ladetto, D. Drandi, 2001, Experimental hematology.

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

M. Boccadoro, A. Pileri, M. Ladetto, 2001, Leukemia.

Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions

A. Pileri, M. Ladetto, D. Caracciolo, 1999, Leukemia.

Clinical relevance of minimal residual disease monitoring in mature B-cell disorders: role of qualitative and quantitative PCR-based strategies

M. Ladetto, L. Giaccone, S. Sametti, 2001 .

Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemia.

D. Caracciolo, C. Tarella, D. Bono, 2005, Contributions to nephrology.

High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments

M. Boccadoro, A. Pileri, M. Ladetto, 2001, Annals of Hematology.

PCR-Detectable N onneoplastic B cl-2/IgH R earrangements A re Common i n N ormal S ubjects a nd C ancer P atients a t D iagnosis but R are i n S ubjects T reated W ith C hemotherapy

M. Boccadoro, A. Pileri, A. Addeo, 2003 .

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia

M. Boccadoro, D. Rossi, G. Gaidano, 2009, Leukemia.

Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.

M. Boccadoro, D. Rossi, G. Gaidano, 2008 .

Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone.

M. Boccadoro, M. Dell'aquila, M. Ladetto, 2003, Experimental hematology.

ituximab Induces Effective Clearance of Minimal esidual Disease in Molecular Relapses of Mantle ell Lymphoma

M. Boccadoro, M. Ladetto, D. Drandi, 2006 .

Radioimmunotherapy and secondary leukemia: a case report.

A. Carbone, C. Carlo-Stella, M. Di Nicola, 2010, Leukemia research.

Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients

A. Pileri, M. Ladetto, L. Bergui, 2000, Medical oncology.

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

M. Napolitano, E. Baldacci, G. Rivolta, 2021, British journal of haematology.

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

A. Frigo, A. Tosetto, C. Santoro, 2022, Journal of clinical medicine.

Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 Italian emergency departments – Results from a survey conducted in Piedmont

C. Linari, A. Borchiellini, I. Ricca, 2022, Acta bio-medica : Atenei Parmensis.

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients

M. Boccadoro, M. Ladetto, A. Gallamini, 2007, Leukemia.

Prognostic significance of blood coagulation tests in lung cancer.

D. Ferrigno, G. Buccheri, I. Ricca, 2001, The European respiratory journal.

Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF

M. Dell'aquila, M. Ladetto, C. Carlo-Stella, 2005, Leukemia.

and is an independent predictor of poor outcome Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma

M. Boccadoro, S. Mariani, M. Ladetto, 2013 .

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

Marina Ruggeri, Andreas Trojan, Federica Cavallo, 2005, Blood.

Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.

A. Gueli, D. Gottardi, A. de Crescenzo, 2013, Blood transfusion = Trasfusione del sangue.

Central Nervous System Relapse in a Patient with Mantle Cell Lymphoma in Continuous Clinical and Molecular Remission at Six Years Since Autografting

A. Pileri, M. Ladetto, D. Drandi, 2001, Leukemia & lymphoma.

Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study

E. Marchesini, A. Coppola, R. De Cristofaro, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemia.

D. Caracciolo, C. Tarella, D. Bono, 2005, Contributions to nephrology.

The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation.

M. Boccadoro, M. Ladetto, D. Caracciolo, 2007 .

Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS.

M. Boccadoro, V. Callea, M. Ladetto, 2006 .